05/09/2024 3:17 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024 11:15 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form EFFECT | |
04/26/2024 3:17 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form ARS | |
04/26/2024 3:13 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 3:15 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024 7:38 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Wills Robert James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 6:00 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Wills Robert James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/08/2024 3:42 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/15/2024 5:00 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) VINCENT RICHARD G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:00 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Yazji Salim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:00 PM | Krishnan Rajesh (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:00 PM | Leavitt Chase C. (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:00 PM | BREITMEYER JAMES B (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 3:05 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 3:31 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 3:59 PM | Krishnan Rajesh (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 3:59 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) VINCENT RICHARD G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:00 PM | BREITMEYER JAMES B (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:01 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Yazji Salim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:01 PM | Leavitt Chase C. (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 3:01 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form 8-K/A | |
07/05/2023 5:57 PM | Krishnan Rajesh (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 5:58 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) Yazji Salim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 5:58 PM | Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer) VINCENT RICHARD G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 5:59 PM | Leavitt Chase C. (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 5:59 PM | BREITMEYER JAMES B (Reporting) Oncternal Therapeutics, Inc. (Issuer) Oncternal Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2023 5:01 AM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 3:31 PM | Oncternal Therapeutics, Inc. (Filer) Oncternal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |